Minireview: The Case for Obesogens
Open accessThe DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Abstract
Obesity and obesity-related disorders, such as type 2 diabetes, hypertension, and cardiovascular disease, are epidemic in Western countries, particularly the United States. The conventional wisdom holds that obesity is primarily the result of a positive energy balance, i.e. too many calories in and too few calories burned. Although it is self-evident that fat cannot be accumulated without a higher caloric intake than expenditure, recent research in a number of laboratories suggests the existence of chemicals that alter regulation of energy balance to favor weight gain and obesity. These obesogens derail the homeostatic mechanisms important for weight control, such that exposed individuals are predisposed to weight gain, despite normal diet and exercise. This review considers the evidence for obesogens, how they might act, and where future research is needed to clarify their relative contribution to the obesity epidemic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some chemicals and plants derived compounds that may regulate the activity of estrogen receptors are potential obesogens [139].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [139]
Citations
Cites
Dynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357 · cited 1×
“onset and increased adipocyte expansion (1).”
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
Increased adipose tissue in male and female estrogen receptor-α knockout mice
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12729 · Cited by 1,282
The Biology of Peroxisome Proliferator-Activated Receptors
Ferré, P. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s43 · Cited by 776
vom Saal, F. S., Akingbemi, B. T., Belcher, S. M., Birnbaum, L. S., Crain, D. A., Eriksen, M., Farabollini, F., Guillette, L. J., Hauser, R., Heindel, J. J., et al. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2007.07.005 · Cited by 712
Stahlhut, R. W., van Wijngaarden, E., Dye, T. D., Cook, S., & Swan, S. H. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9882 · Cited by 646
Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates
Grün, F., Watanabe, H., Zamanian, Z., Maeda, L., Arima, K., Cubacha, R., Gardiner, D. M., Kanno, J., Iguchi, T., & Blumberg, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0367 · Cited by 612
Self-citationRubin, B. S., Murray, M. K., Damassa, D. A., King, J. C., & Soto, A. M. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109675 · Cited by 604
Thomas, P., & Dong, J. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.017 · Cited by 603
Smith, S. R., Lovejoy, J. C., Greenway, F., Ryan, D., deJonge, L., de la Bretonne, J., Volafova, J., & Bray, G. A. (2001) · Metabolism · doi:10.1053/meta.2001.21693 · Cited by 596
Endocrine disrupters as obesogens
Grün, F., & Blumberg, B. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.018 · Cited by 582
Self-citationNyirenda, M. J., Lindsay, R. S., Kenyon, C. J., Burchell, A., & Seckl, J. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1567 · Cited by 574
Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation
Ristow, M., Müller-Wieland, D., Pfeiffer, A., Krone, W., & Kahn, C. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391403 · Cited by 545
The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue
de Jesus, L. A., Carvalho, S. D., Ribeiro, M. O., Schneider, M. J., Kim, S.-W., Harney, J. W., Larsen, P. R., & Bianco, A. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13803 · Cited by 537
Activation of PPAR and PPAR by Environmental Phthalate Monoesters
Hurst, C. H., & Waxman, D. J. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg145 · Cited by 510
Vanden Heuvel, J. P., Thompson, J. T., Frame, S. R., & Gillies, P. J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl014 · Cited by 479
TAKEUCHI, T., TSUTSUMI, O., IKEZUKI, Y., TAKAI, Y., & TAKETANI, Y. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.165 · Cited by 454
Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
Haarbo, J., Marslew, U., Gotfredsen, A., & Christiansen, C. (1991) · Metabolism · doi:10.1016/0026-0495(91)90037-w · Cited by 441
Koro, C. E., Fedder, D. O., L'Italien, G. J., Weiss, S., Magder, L., Kreyenbuhl, J., Revicki, D., & Buchanan, R. (2002) · BMJ · doi:10.1136/bmj.325.7358.243 · Cited by 421 · cited 1×
“For example, patients undergoing olanzapine therapy experience a dose-dependent weight gain of 5–10 kg/yr (27) compared with patients on therapy with typical antipsychotic drugs (29, 30).”
BackgroundTakacs, M. L., & Abbott, B. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl135 · Cited by 396
trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals
Maloney, E. K., & Waxman, D. J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8809 · Cited by 374
Feige, J. N., Gelman, L., Rossi, D., Zoete, V., Métivier, R., Tudor, C., Anghel, S. I., Grosdidier, A., Lathion, C., Engelborghs, Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702724200 · Cited by 356
Kanayama, T., Kobayashi, N., Mamiya, S., Nakanishi, T., & Nishikawa, J.-I. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008409 · Cited by 354
Welberg, L. A. M., Seckl, J. R., & Holmes, M. C. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00958.x · Cited by 348
The Hypothalamic‐Pituitary‐Adrenal Axis Activity in Obesity and the Metabolic Syndrome
PASQUALI, R., VICENNATI, V., CACCIARI, M., & PAGOTTO, U. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.009 · Cited by 332
Effects of endocrine disruptors on obesity
Newbold, R. R., Padilla‐Banks, E., Jefferson, W. N., & Heindel, J. J. (2008) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00858.x · Cited by 313
Safety issues and prospects for future generations of PPAR modulators
RUBENSTRUNK, A., HANF, R., HUM, D., FRUCHART, J., & STAELS, B. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.003 · Cited by 309 · cited 1×
“However, TZDs lead to peripheral edema and persistent weight gain with prolonged use (12, 13).”
BackgroundGrün, F., & Blumberg, B. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9049-x · Cited by 305
Self-citationThe Effects of Novel Antipsychotics on Glucose and Lipid Levels
Wirshing, D. A., Jennifer A., J. A., Meng, L. R., Ballon, J. S., Marder, S. R., & Wirshing, W. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1002 · Cited by 294
Lindsay, R. S., Lindsay, R. M., Waddell, B. J., & Seckl, J. R. (1996) · Diabetologia · doi:10.1007/s001250050573 · Cited by 283
Larsen, T. M., Toubro, S., & Astrup, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802223 · Cited by 282
Miyawaki, J., Sakayama, K., Kato, H., Yamamoto, H., & Masuno, H. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e486 · Cited by 282
The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes
Hara, K., Okada, T., Tobe, K., Yasuda, K., Mori, Y., Kadowaki, H., Hagura, R., Akanuma, Y., Kimura, S., Ito, C., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2605 · Cited by 273
Occurrence of Butyltin Compounds in Human Blood
Kannan, K., Senthilkumar, K., & Giesy, J. P. (1999) · Environmental Science & Technology · doi:10.1021/es990011w · Cited by 261
Adipocyte-Specific Glucocorticoid Inactivation Protects Against Diet-Induced Obesity
Kershaw, E. E., Morton, N. M., Dhillon, H., Ramage, L., Seckl, J. R., & Flier, J. S. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1023 · Cited by 253
Masuno, H. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi088 · Cited by 246
Evaluation of a Quantitative Magnetic Resonance Method for Mouse Whole Body Composition Analysis
Tinsley, F. C., Taicher, G. Z., & Heiman, M. L. (2004) · Obesity Research · doi:10.1038/oby.2004.20 · Cited by 244
Masuno, H., Kidani, T., Sekiya, K., Sakayama, K., Shiosaka, T., Yamamoto, H., & Honda, K. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30108-5 · Cited by 233
Inoue, K., Kato, K., Yoshimura, Y., Makino, T., & Nakazawa, H. (2000) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00351-0 · Cited by 222
Rieusset, J., Touri, F., Michalik, L., Escher, P., Desvergne, B., Niesor, E., & Wahli, W. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0036 · Cited by 214
Kim, H.-K., Nelson-Dooley, C., Della-Fera, M. A., Yang, J.-Y., Zhang, W., Duan, J., Hartzell, D. L., Hamrick, M. W., & Baile, C. A. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.2.409 · Cited by 206
Danilovich, N., Babu, P. S., Xing, W., Gerdes, M., Krishnamurthy, H., & Sairam, M. R. (2000) · Endocrinology · doi:10.1210/endo.141.11.7765 · Cited by 203
Rosen, M. B., Lee, J. S., Ren, H., Vallanat, B., Liu, J., Waalkes, M. P., Abbott, B. D., Lau, C., & Corton, J. C. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn025 · Cited by 200
Genistein Affects Adipose Tissue Deposition in a Dose-Dependent and Gender-Specific Manner
Penza, M., Montani, C., Romani, A., Vignolini, P., Pampaloni, B., Tanini, A., Brandi, M. L., Alonso-Magdalena, P., Nadal, A., Ottobrini, L., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0365 · Cited by 193
Butyltin residues in livers of humans and wild terrestrial mammals and in plastic products
Takahashi, S., Mukai, H., Tanabe, S., Sakayama, K., Miyazaki, T., & Masuno, H. (1999) · Environmental Pollution · doi:10.1016/s0269-7491(99)00068-8 · Cited by 192
Wolf, C. J., Fenton, S. E., Schmid, J. E., Calafat, A. M., Kuklenyik, Z., Bryant, X. A., Thibodeaux, J., Das, K. P., White, S. S., Lau, C. S., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl159 · Cited by 186
trans-Activation of PPAR and Induction of PPAR Target Genes by Perfluorooctane-Based Chemicals
Shipley, J. M. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh130 · Cited by 169
Accumulation and trophic transfer of organotins in a marine food web from the Danish coastal waters
Strand, J., & Jacobsen, J. A. (2005) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2005.02.039 · Cited by 162
Bisphenol A affects glucose transport in mouse 3T3‐F442A adipocytes
Sakurai, K., Kawazuma, M., Adachi, T., Harigaya, T., Saito, Y., Hashimoto, N., & Mori, C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705520 · Cited by 156 · cited 1×
“In addition to its ability to bind to ERs, BPA has been shown to activate the membrane ER at low doses (50) via the insulin-dependent phosphatidylinositol 3-kinase/Akt kinase pathway, enhancing glucose uptake (45, 48).”
BackgroundDosing the antipsychotic medication olanzapine.
Nemeroff, C. B. (1997) · PubMed · Cited by 153
Perinatal exposure to environmental estrogens and the development of obesity
Newbold, R. R., Padilla‐Banks, E., Snyder, R. J., & Jefferson, W. N. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600259 · Cited by 141
Wu, J., Oka, J., Tabata, I., Higuchi, M., Toda, T., Fuku, N., Ezaki, J., Sugiyama, F., Uchiyama, S., Yamada, K., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060208 · Cited by 140
Gene Profiling in the Livers of Wild-type and PPARα-Null Mice Exposed to Perfluorooctanoic Acid
Rosen, M. B., Abbott, B. D., Wolf, D. C., Corton, J. C., Wood, C. R., Schmid, J. E., Das, K. P., Zehr, R. D., Blair, E. T., & Lau, C. (2008) · Toxicologic Pathology · doi:10.1177/0192623308318208 · Cited by 132
Environmental chemical tributyltin augments adipocyte differentiation
Inadera, H., & Shimomura, A. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.05.015 · Cited by 125
Phrakonkham, P., Viengchareun, S., Belloir, C., Lombès, M., Artur, Y., & Lavier, M.-C. C. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.02.006 · Cited by 119
PERFLUOROALKYL ACIDS: What Is the Evidence Telling Us?
Betts, K. S. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.115-a250 · Cited by 119
Festuccia, W. T., Oztezcan, S., Laplante, M., Berthiaume, M., Michel, C., Dohgu, S., Denis, R. G., Brito, M. N., Brito, N. A., Miller, D. S., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1553 · Cited by 111
Effect of estrogen deficiency in the male: the ArKO mouse model
Murata, Y., Robertson, K. M., Jones, M. E. E., & Simpson, E. R. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00090-4 · Cited by 111
Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates
Atanasov, A. G., Tam, S., Röcken, J. M., Baker, M. E., & Odermatt, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01359-7 · Cited by 110
Ruetsch, O., Viala, A., Bardou, H., Martin, P., & Vacheron, M. N. (2005) · L Encéphale · doi:10.1016/s0013-7006(05)82412-1 · Cited by 106
Ruhlen, R. L., Howdeshell, K. L., Mao, J., Taylor, J. A., Bronson, F. H., Newbold, R. R., Welshons, W. V., & vom Saal, F. S. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10448 · Cited by 102 · cited 1×
“Despite a lower than normal birth weight, both males and females developed obesity at puberty when maintained on soy-free chow (21).”
BackgroundTomlinson, J. W., Sherlock, M., Hughes, B., Hughes, S. V., Kilvington, F., Bartlett, W., Courtney, R., Rejto, P., Carley, W., & Stewart, P. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2325 · Cited by 98
Paulik, M. A., Buckholz, R. G., Lancaster, M. E., Dallas, W. S., Hull-Ryde, E. A., Weiel, J. E., & Lenhard, J. M. (1998) · Pharmaceutical Research · doi:10.1023/a:1011993019385 · Cited by 90
Disruption of glucocorticoid action by environmental chemicals: Potential mechanisms and relevance
Odermatt, A., Gumy, C., Atanasov, A. G., & Dzyakanchuk, A. A. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.010 · Cited by 88
Nakano, R., Kurosaki, E., Yoshida, S., Yokono, M., Shimaya, A., Maruyama, T., & Shibasaki, M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.023 · Cited by 81
Atanasov, A. G., Nashev, L. G., Tam, S., Baker, M. E., & Odermatt, A. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8209 · Cited by 80
Androgen receptor functions from reverse genetic models
Μatsumoto, T., Takeyama, K., Sato, T., & Kato, S. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00231-0 · Cited by 78
Blood levels of organotin compounds and their relation to fish consumption in Finland
Rantakokko, P., Turunen, A. W., Verkasalo, P. K., Kiviranta, H., Männistö, S., & Vartiainen, T. (2008) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2008.03.017 · Cited by 68
Masuno, H., Okamoto, S., Iwanami, J., Honda, K., Shiosaka, T., Kidani, T., Sakayama, K., & Yamamoto, H. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg203 · Cited by 67
Tsumura, Y., ISHIMITSU, S., Saito, I., Sakai§, H., Tsuchida§, Y., & TONOGAI, Y. (2003) · Food Additives & Contaminants · doi:10.1080/0265203031000122021 · Cited by 66
Cooke, G. M., Forsyth, D. S., Bondy, G. S., Tachon, R., Tague, B., & Coady, L. (2008) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287390701801653 · Cited by 58
Janer, G., Navarro, J. C., & Porte, C. (2007) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2007.04.009 · Cited by 57
Nishiu, J., Ito, M., Ishida, Y., Kakutani, M., Shibata, T., Matsushita, M., & Shindo, M. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00536.x · Cited by 56
TBTC induces adipocyte differentiation in human bone marrow long term culture
Carfì, M., Croera, C., Ferrario, D., Campi, V., Bowe, G., Pieters, R. H. H., & Gribaldo, L. (2008) · Toxicology · doi:10.1016/j.tox.2008.03.025 · Cited by 56
Carlin, K. M., Vale, W. W., & Bale, T. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511320103 · Cited by 55
The Metabolic Syndrome During Atypical Antipsychotic Drug Treatment: Mechanisms and Management
Baptista, T., De Mendoza, S., Beaulieu, S., Bermúdez, A., & Martinez, M. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.290 · Cited by 42
ITSUKI-YONEDA, A., KIMOTO, M., TSUJI, H., HIEMORI, M., & YAMASHITA, H. (2007) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.60478 · Cited by 40
Characterization of the adipose tissue atrophy induced by peroxisome proliferators in mice
Xie, Y., Yang, Q., Nelson, B. D., & DePierre, J. W. (2002) · Lipids · doi:10.1007/s11745-002-0873-7 · Cited by 36
Computational Screening of Phthalate Monoesters for Binding to PPARγ
Kaya, T., Mohr, S. C., Waxman, D. J., & Vajda, S. (2006) · Chemical Research in Toxicology · doi:10.1021/tx050301s · Cited by 30
Perinatal Programming of Central Obesity and the Metabolic Syndrome: Role of Glucocorticoids
Achard, V., Boullu‐Ciocca, S., Desbrière, R., & Grino, M. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.129 · Cited by 23
The new clinical trials with thiazolidinediones – DREAM, ADOPT, and CHICAGO: promises fulfilled?
Goldberg, R. B. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32821f604c · Cited by 22
Military Infrared Technology Advances Diabetes Research
Tepper, M., Persinger, R. L., Daniels, K. K., Chomicz, S., & Teich, J. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503321827911 · Cited by 3
Cited by
Endocrine disrupting chemicals and disease susceptibility
Schug, T. T., Janesick, A., Blumberg, B., & Heindel, J. J. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.08.007 · Cited by 1,087
Self-citationPhthalates impact human health: Epidemiological evidences and plausible mechanism of action
Benjamin, S., Masai, E., Kamimura, N., Takahashi, K., Anderson, R. C., & Faisal, P. A. (2017) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2017.06.036 · Cited by 747
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
“Some chemicals and plants derived compounds that may regulate the activity of estrogen receptors are potential obesogens [139].”
BackgroundEndocrine disrupters as obesogens
Grün, F., & Blumberg, B. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.018 · Cited by 582
Self-citationTrasande, L., Attina, T. M., & Blustein, J. (2012) · JAMA · doi:10.1001/2012.jama.11461 · Cited by 464
“Obesity develops over time, and causation cannot be inferred from a crosssectional association of urinary BPA concentration with increased body mass, even when consistent with increasing laboratory evidence.(28,29) Endocrine-disrupting chemicals such as BPA may have their greatest effect in early life(30) rather than…”
Background
Metadata
- Authors
- Grün, F., & Blumberg, B.
- Affiliations
- Departments of Developmental and Cell Biology (B.B., F.G.), Irvine, California 92697-2300
- University of California, Irvine (US)
- Corresponding author
- Blumberg, Bruce
- ORCID
- Blumberg, Bruce
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-08-01
- Volume
- 23
- Issue
- 8
- Pages
- 1127-1134
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC2718750
- OpenAlex
- W1978096815
- Cited by
- 188
- References
- 82
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 15 · 2021: 9 · 2020: 14 · 2019: 12 · 2018: 5 · 2017: 11 · 2016: 19 · 2015: 19 · 2014: 22 · 2013: 13 · 2012: 23
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of California, Irvine
- National Institute of Environmental Health Sciences (R01ES015849)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- obesogens, obesity, energy balance, endocrine disruptors, weight gain, type 2 diabetes, hypertension, cardiovascular disease, obesity epidemic, endocrine regulation of metabolism
- MeSH terms
- Adipose Tissue, Animals, Disease Models, Animal, Endocrine System, Energy Metabolism, Environment, Female, Homeostasis, Humans, Male, Obesity, Steroids, Comorbidity, Genetic Predisposition to Disease, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.